Argenx (ARGX) is a publicly traded Healthcare sector company. As of October 3, 2026, ARGX trades at $936.52 with a market cap of $59.99B and a P/E ratio of 0.00. ARGX moved -2.33% today. Year to date, ARGX is +11.43%; over the trailing twelve months it is +21.98%. Its 52-week range spans $510.06 to $1,072.75. Analyst consensus is strong buy with an average price target of $1,180.25. Rallies surfaces ARGX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Argenx (ARGX) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. ARGX moved -2.33% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $936.52 |
| Market Cap | $59.99B |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $1,072.75 |
| 52-Week Low | $510.06 |
| Volume | 245.87K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
21 analysts cover ARGX: 0 strong buy, 20 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $1,180.25.